Influence of Cytokine Release Syndrome in Severe COVID-19 Patients Treated With Tocilizumab Over the Quantiferon TB Gold Plus Results

被引:4
作者
Sanchez-Martinez, Francesca [1 ]
Arenas-Miras, Mar [1 ]
Jove-Caballe, Neus [1 ]
Knobel-Freud, Hernando [1 ]
机构
[1] Hosp del Mar, Infect Dis Serv, Barcelona, Spain
来源
ARCHIVOS DE BRONCONEUMOLOGIA | 2021年 / 57卷
关键词
TUBERCULOSIS;
D O I
10.1016/j.arbres.2021.02.003
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:58 / 59
页数:2
相关论文
共 10 条
[1]   Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools [J].
Fu, Yajing ;
Cheng, Yuanxiong ;
Wu, Yuntao .
VIROLOGICA SINICA, 2020, 35 (03) :266-271
[2]   Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? [J].
Huertas, Alice ;
Montani, David ;
Savale, Laurent ;
Pichon, Jeremie ;
Tu, Ly ;
Parent, Florence ;
Guignabert, Christophe ;
Humbert, Marc .
EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (01)
[3]   Tocilizumab for severe COVID-19: a systematic review and meta-analysis [J].
Lan, Shao-Huan ;
Lai, Chih-Cheng ;
Huang, Hui-Ting ;
Chang, Shen-Peng ;
Lu, Li-Chin ;
Hsueh, Po-Ren .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (03)
[4]   Coinfection of Tuberculosis Pneumonia and COVID-19 in a Patient Vaccinated with Bacille Calmette-Guérin (BCG): Case Report [J].
Michelangelo Luciani ;
Enrico Bentivegna ;
Valerio Spuntarelli ;
Piera Amoriello Lamberti ;
Ludovica Guerritore ;
Dario Chiappino ;
Gabriele Nalli ;
Maria Proietta ;
Flavia Del Porto ;
Paolo Martelletti ;
Giorgio Sesti .
SN Comprehensive Clinical Medicine, 2020, 2 (11) :2419-2422
[5]   Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection [J].
Pai, Madhukar ;
Denkinger, Claudia M. ;
Kik, Sandra V. ;
Rangaka, Molebogeng X. ;
Zwerling, Alice ;
Oxlade, Olivia ;
Metcalfe, John Z. ;
Cattamanchi, Adithya ;
Dowdy, David W. ;
Dheda, Keertan ;
Banaei, Niaz .
CLINICAL MICROBIOLOGY REVIEWS, 2014, 27 (01) :3-20
[6]  
Pathak L, 2020, BIORXIV
[7]   Linezolid for multidrug-resistant tuberculosis: How should we approach it? [J].
Santin, Miguel .
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2016, 34 (02) :83-84
[8]   The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement [J].
Solovic, I. ;
Sester, M. ;
Gomez-Reino, J. J. ;
Rieder, H. L. ;
Ehlers, S. ;
Milburn, H. J. ;
Kampmann, B. ;
Hellmich, B. ;
Groves, R. ;
Schreiber, S. ;
Wallis, R. S. ;
Sotgiu, G. ;
Scholvinck, E. H. ;
Goletti, D. ;
Zellweger, J. P. ;
Diel, R. ;
Carmona, L. ;
Bartalesi, F. ;
Ravn, P. ;
Bossink, A. ;
Duarte, R. ;
Erkens, C. ;
Clark, J. ;
Migliori, G. B. ;
Lange, C. .
EUROPEAN RESPIRATORY JOURNAL, 2010, 36 (05) :1185-1206
[9]   ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors) [J].
Winthrop, K. L. ;
Mariette, X. ;
Silva, J. T. ;
Benamu, E. ;
Calabrese, L. H. ;
Dumusc, A. ;
Smolen, J. S. ;
Aguado, J. M. ;
Fernandez-Ruiz, M. .
CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 :S21-S40
[10]   Effective treatment of severe COVID-19 patients with tocilizumab [J].
Xu, Xiaoling ;
Han, Mingfeng ;
Li, Tiantian ;
Sun, Wei ;
Wang, Dongsheng ;
Fu, Binqing ;
Zhou, Yonggang ;
Zheng, Xiaohu ;
Yang, Yun ;
Li, Xiuyong ;
Zhang, Xiaohua ;
Pan, Aijun ;
Wei, Haiming .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (20) :10970-10975